Galacto oligosaccharide is a chain of galactose compounded with glucose molecules, which are primarily found in lactose present in cow’s milk a number of root vegetable species, and bean varieties. Galacto oligosaccharides move in an undigested form to the colon, supporting the growth of healthy bacteria and bowel movement.
The global galacto oligosaccharide market is projected to grow at a healthy CAGR of ~ 7.7%, to reach a value of US$ 621 million. This will account for a sales of 104,812.6 metric tons. This growth can be largely attributed to the applications of galacto oligosaccharides in major nutraceutical products, which aids in lower pH and better stability in higher temperature conditions.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Galacto oligosaccharides are rapidly gaining in terms of adoption rates for the global infant nutrition sector, which can be attributed to awareness about therapeutic effects on immunity and gut health. The rise in the incidences of lactose intolerance on the other hand is restricting the use of animal based galacto oligosaccharides.
Consequently, the development of plant based galacto oligosaccharides has proven to be effective in meeting the nutritional requirements for the population of lactose intolerant people. This trend is also expected to have a positive influence in commercialization in infant nutrition products. Spurred by this, the demand for both liquid and powder GOS is expected to rise in the coming years.
The worldwide galacto oligosaccharide market is largely consolidated with major players holding major market share. Some of the key players in the sector include names such as Quantum High-tech, Friesland Campina, Samyang Corporation, Ingredient Inc., King Prebiotic, Diary Crest, Kerry Inc., and Yakult Pharmaceutical among others.
Major players are seeking to expand their services and products to a number of countries, and also investing in new products of prebiotics, to increase diversification as per consumer needs. Manufacturers are also pushing for new production facilities, strategic collaborations, and research and development activities to strengthen their portfolios in a competitive industry.
Europe is currently the largest regional market for galacto oligosaccharides accounting for more than 40 % of the overall market share at a strong CAGR of more than 8 %. This growth can be attributed to higher focus on purity and research on GOS to meet the needs of premium applications, which will generate new, lucrative opportunities in the upcoming years.
On the other hand, the Asia Pacific excluding Japan region currently accounts for more than a quarter of the global market share and is growing at higher CAGR surpassing 9.5 %, owing to growing consumer awareness about prebiotics and the development of plant based GOS variants.
In order to offer cost advantage to companies, local players have started offering prebiotic ingredients at comparatively lower prices, primarily in countries such as China and India. In addition, growing demand for functional food products in these countries is expected to increase options for various new entrants in the prebiotic ingredients market in the near future.
Strict legislation on the uses of prebiotics is expected to negatively impact the galacto oligosaccharide market. However, the impact will be offset by growing consumer interest in natural prebiotics and probiotics, and will generate new opportunities with approvals coming from bodies such as the United States Food and Drug Administration, driving opportunities for GOS applications in nutraceuticals and infant nutrition formulations.
The global galacto oligosaccharides market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.
The galacto oligosaccharide market is likely to secure a CAGR of 7.5% through 2032.
The galacto oligosaccharide market size is estimated to cross US$ 621 Mn by 2032.
The galacto oligosaccharide market is likely to record a value of US$ 301 Mn in 2022.
Europe is likely to lead the galacto oligosaccharide market.
1. Executive Summary 1.2. Global GOS (Galactooligosaccharide) market Country Analysis 1.3. Vertical Specific Market Penetration 1.4. Application - Product Mapping 1.5. Competition Blueprint 1.6. Technology Time Line Mapping 1.7. FMI Analysis and Recommendations 2. Market Overview 2.1. Market Introduction 2.2. Market Definition 2.3. Market Taxonomy 3. Market Dynamics 3.1. Drivers 3.1.1. Economic Drivers 3.1.2. Supply Side Drivers 3.1.3. Demand Side Drivers 3.2. Market Restraints 3.3. Market Trends 3.4. Trend Analysis- Impact on Time Line (2019-2029) 4. Macro-economic Factors 4.1. Expanding Global Food & Beverage Industry 4.2. Government Policies Effecting the Framework 4.3. GDP Growth 4.4. High research and development 4.5. Increasing Number of Internet Users 4.6. Change in technology in animal feed industry 4.6.1. Retail Sales 4.6.2. Per-Capita Consumption Expenditure 4.6.3. Increase in Geriatric Population having an effect in the Market 4.6.4. Urbanization 4.6.5. Consumer Price Index 5. Food & Beverage Industry Outlook 5.1. Rise in Consumption of Food Items Across the Globe: 5.2. Global Food and Beverages Sector 5.3. Mega Trends Influencing the Food & Beverages Industry 6. Forecast Factors 6.1. Adoption of public and private Safety Standards by manufactures 6.2. Transparency - the embracing trend 6.3. Rising demand for safe and quality food products among consumers 6.4. Demand for ethical and sustainable products 7. Key Regulations 7.1. Europe Food & Safety Authority 7.2. Food Packaging Claims 7.3. FSSAI 7.4. Food and Drug Administration (FDA) 7.5. EU agri-food trade 7.6. Label claim 8. Value Chain Analysis 8.1. Profitability and Gross Margin Analysis By Competition 8.2. List of Active Participants- By Region 8.2.1. Raw Material Suppliers 8.2.2. Product Manufacturers 8.2.3. Distributors/Suppliers/Wholesalers 9. Global GOS (Galactooligosaccharide) Market - Pricing Analysis 9.1. Regional Pricing Analysis (US$/MT ) By Product 9.2. Pricing Break-up 9.2.1. Producer Level Pricing 9.2.2. Distributor Level Pricing 9.2.3. Retail Pricing 9.3. Global Average Pricing Analysis Benchmark 10. Global GOS (Galactooligosaccharide) Market Demand Analysis 2014-2018 and Forecast, 2019-2029 10.1. Historical Market Volume MT Analysis,2014-2018 10.2. Current and Future Market Volume MT Projections, 2019-2029 10.2.1. Market Incremental Value 10.2.2. Absolute $ Opportunity Analysis 11. Global GOS (Galactooligosaccharide) Market Analysis 2014-2018 and Forecast 2019-2029, By Region 11.1. Introduction 11.2. Historical Market Size Value (US$ Mn) and Volume(MT ) Analysis By Region,2014 - 2018 11.3. Current Market Size Value (US$ Mn) and Volume(MT ) Analysis and Forecast By Region, 2019 - 2029 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. APEJ 11.3.5. Japan 11.3.6. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. Global GOS (Galactooligosaccharide) Market Analysis 2014-2018 and Forecast 2019-2029, By Product Form Type 12.1. Introduction / Key Findings 12.2. Historical Market Size value (US$ Mn) and Volume (MT ) Analysis By Product Form Type,2014 -2018 12.3. Current and Future Market Size Value (US$ Mn) and Volume (MT ) Analysis and Forecast By Product Form Type, 2019 - 2029 12.3.1. Liquid Form 12.3.2. Powder Form 12.4. Market Attractiveness Analysis By Product Form Type 13. Global GOS (Galactooligosaccharide) Market Analysis 2014-2018 and Forecast 2019-2029, By Primary Function Type 13.1. Introduction / Key Findings 13.2. Historical Market Size value (US$ Mn) and Volume (MT ) Analysis By Primary Function Type, 2014 -2018 13.3. Current and Future Market Size Value (US$ Mn) and Volume (MT ) Analysis and Forecast By Primary Function Type, 2019 - 2029 13.3.1. Prebiotics 13.3.2. Sweetener 13.4. Market Attractiveness Analysis By Primary Function Type 14. Global GOS (Galactooligosaccharide) Market Analysis 2014-2018 and Forecast 2019-2029, By End-User Channel 14.1. Introduction / Key Findings 14.2. Historical Market value (US$ Mn) and Volume (MT ) (MT ) Analysis By End-User Channel,2014 - 2018 14.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By End-User Channel , 2019 - 2029 14.3.1. Food & Beverage 14.3.2. Animal Feed 14.3.3. Pharmaceuticals & Personal Care 14.4. Market Attractiveness Analysis By End-User Channel 15. North America GOS (Galactooligosaccharide) Market Analysis 2014-2018 and Forecast 2019-2029 15.1. Introduction 15.2. Historical Market Size Value (US$ Mn) and Volume (MT ) Trend Analysis By Market Taxonomy,2014 - 2018 15.3. Market Size Value (US$ Mn) and Volume (MT ) Forecast By Market Taxonomy, 2019 - 2029 15.3.1. By Country 15.3.1.1. U.S. 15.3.1.2. Canada 15.3.2. By Product Form Type 15.3.3. By Primary Function Type 15.3.4. By End-User Channel 15.4. Market Attractiveness Analysis 15.4.1. By country 15.4.2. By Product Form Type 15.4.3. By Primary Function Type 15.4.4. By End-User Channel 16. Latin America GOS (Galactooligosaccharide) Market Analysis 2014-2018 and Forecast 2019-2029 16.1. Introduction 16.2. Historical Market Size (US$ Mn) and Volume (MT ) Trend Analysis By Market Taxonomy,2014 - 2018 16.3. Market Size (US$ Mn) and Volume (MT ) Forecast By Market Taxonomy, 2019 - 2029 16.3.1. By Country 16.3.1.1. Brazil 16.3.1.2. Mexico 16.3.1.3. Chile 16.3.1.4. Peru 16.3.1.5. Rest of Latin America 16.3.2. By Product Form Type 16.3.3. By Primary Function Type 16.3.4. By End-User Channel 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product Form Type 16.4.3. By Primary Function Type 16.4.4. By End-User Channel 17. Europe GOS (Galactooligosaccharide) Market Analysis 2014-2018 and Forecast 2019-2029 17.1. Introduction 17.2. Historical Market Size value (US$ Mn) and Volume (MT ) Trend Analysis By Market Taxonomy,2014 - 2018 17.3. Market Size value (US$ Mn) and Volume(MT ) Forecast By Market Taxonomy, 2019 - 2029 17.3.1. By Country 17.3.1.1. EU4 17.3.1.2. UK 17.3.1.3. BENELUX 17.3.1.4. Nordic 17.3.1.5. Eastern Europe 17.3.1.6. Rest of Europe 17.3.1.7. 17.3.2. By Product Form Type 17.3.3. By Primary Function Type 17.3.4. By End-User Channel 17.4. By Application Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product Form Type 17.4.3. By Primary Function Type 17.4.4. By End-User Channel 18. APEJ GOS (Galactooligosaccharide) Market Analysis 2014-2018 and Forecast 2019-2029 18.1. Introduction 18.2. Historical Market Size (US$ Mn) and Volume (MT ) Trend Analysis By Market Taxonomy,2014 - 2018 18.3. Market Size Value (US$ Mn) and Volume (MT ) Forecast By Market Taxonomy, 2019 - 2029 18.3.1. By Country 18.3.1.1. China 18.3.1.2. India 18.3.1.3. ASEAN 18.3.1.4. Australia & New Zealand 18.3.1.5. Rest of APEJ 18.3.2. By Product Form Type 18.3.3. By Primary Function Type 18.3.4. By End-User Channel 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product Form Type 18.4.3. By Primary Function Type 18.4.4. By End-User Channel 19. Japan Europe GOS (Galactooligosaccharide) Market Analysis 2014-2018 and Forecast 2019-2029 19.1. Introduction 19.2. Historical Market Size value (US$ Mn) and Volume (MT ) Trend Analysis By Market Taxonomy,2014 - 2018 19.3. Market Size value (US$ Mn) and Volume(MT ) Forecast By Market Taxonomy, 2019 - 2029 19.3.1. By Nature 19.3.2. By Product Form Type 19.3.3. By Primary Function Type 19.3.4. By End-User Channel 19.4. By Application Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product Form Type 19.4.3. By Primary Function Type 19.4.4. By End-User Channel 20. Middle East and Africa GOS (Galactooligosaccharide) Market Analysis 2014-2018 and Forecast 2019-2029 20.1. Introduction 20.2. Historical Market Size value (US$ Mn) and Volume (MT ) Trend Analysis By Market Taxonomy,2014 - 2018 20.3. Market Size Value (US$ Mn) and Volume (MT ) Forecast By Market Taxonomy, 2019 - 2029 20.3.1. By Country 20.3.1.1. Greter China 20.3.1.2. India 20.3.1.3. ASEAN Countries 20.3.1.4. South Korea 20.3.1.5. AZN 20.3.1.6. Rest of APEJ 20.3.2. By Product Form Type 20.3.3. By Primary Function Type 20.3.4. By End-User Channel 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product Form Type 20.4.3. By Primary Function Type 20.4.4. By End-User Channel 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Benchmarking 21.3. Competition Deep Dive (Tentative List, can change during the course of research) 21.4. GOS (Galactooligosaccharide) Manufacturers 21.4.1. Yakult Pharmaceuticals Pvt Ltd 21.4.1.1. Overview 21.4.1.2. Product Portfolio 21.4.1.3. Profitability by Market Segments (Product/Channel/Region) 21.4.1.4. SWOT analysis 21.4.1.5. Sales Footprint 21.4.2. Royal Friesland Campina N.V 21.4.2.1. Overview 21.4.2.2. Product Portfolio 21.4.2.3. Profitability by Market Segments (Product/Channel/Region) 21.4.2.4. SWOT analysis 21.4.2.5. Sales Footprint 21.4.3. Nissin Sugar Co., Ltd 21.4.3.1. Overview 21.4.3.2. Product Portfolio 21.4.3.3. Profitability by Market Segments (Product/Channel/Region) 21.4.3.4. SWOT analysis 21.4.3.5. Sales Footprint 21.4.4. Ingredion Incorporated. 21.4.4.1. Overview 21.4.4.2. Product Portfolio 21.4.4.3. Profitability by Market Segments (Product/Channel/Region) 21.4.4.4. SWOT analysis 21.4.4.5. Sales Footprint 21.4.5. Kerry Inc. 21.4.5.1. Overview 21.4.5.2. Product Portfolio 21.4.5.3. Profitability by Market Segments (Product/Channel/Region) 21.4.5.4. SWOT analysis 21.4.5.5. Sales Footprint 21.4.6. Quantum Hi-Tech (China) Biological Co., Ltd. 21.4.6.1. Overview 21.4.6.2. Product Portfolio 21.4.6.3. Profitability by Market Segments (Product/Channel/Region) 21.4.6.4. SWOT analysis 21.4.6.5. Sales Footprint 21.4.7. Dairy Crest. 21.4.7.1. Overview 21.4.7.2. Product Portfolio 21.4.7.3. Profitability by Market Segments (Product/Channel/Region) 21.4.7.4. SWOT analysis 21.4.7.5. Sales Footprint 21.4.8. Baolingbao Biology Co., Ltd. 21.4.8.1. Overview 21.4.8.2. Product Portfolio 21.4.8.3. Profitability by Market Segments (Product/Channel/Region) 21.4.8.4. SWOT analysis 21.4.8.5. Sales Footprint 21.4.9. Samyang Corporation. 21.4.9.1. Overview 21.4.9.2. Product Portfolio 21.4.9.3. Profitability by Market Segments (Product/Channel/Region) 21.4.9.4. SWOT analysis 21.4.9.5. Sales Footprint 21.4.10. New Francisco Biotech Company 21.4.10.1. Overview 21.4.10.2. Product Portfolio 21.4.10.3. Profitability by Market Segments (Product/Channel/Region) 21.4.10.4. SWOT analysis 21.4.10.5. Sales Footprint 21.5. Appendix 22. Research Methodology 23. Assumptions and Acronyms Used
Explore Food and Beverage Insights
View Reports